PolyPid Ltd. (PYPD) stock analysis

In our weekly check, PolyPid Ltd. is graded F (A to F). Of 19 checks on debt, profit, cash flow and trend: 6 pass, warnings: 4, red flags: 9.

About PolyPid Ltd.

PolyPid Ltd. is a Healthcare company (Biotechnology) based in Israel, listed on NASDAQ as PYPD.

What our checks show for PYPD

Red flags

• Weak EPS forecast
• Analysts expect the net margin to shrink by 27.5 points from today's 0%.
• Earnings per share fell 71.1% a year over the last 3 years.
• The net margin is only 0%: little room if costs rise.
• A small company (market value $109 million): usually riskier and followed by fewer analysts.
• The price swings a lot: 61% annual volatility. Expect large ups and downs.
• The stock has fallen as much as 100% from a peak. Would you have held through that?
• The share count grew by 1064% in 2 years: each shareholder owns a smaller slice.
• Pay in shares equals 0% of free cash flow: it dilutes shareholders.

Warning signs

• Free cash flow is only 0% of revenue.
• The stock is still below its previous peak.
• Beta 1.38: the stock usually moves more than the market, both up and down.
• Thinly traded (about 118 thousand shares a day): buying and selling can move the price.

Strengths

• Debt is low: 0.29x equity.
• Operating profit covers interest 48.5 times over.

Next earnings report: 2026-11-11

Similar companies

CLLS · AVXL · OTLK · ENGN · ADAG · COYA

Questions

What grade does PolyPid Ltd. (PYPD) have?

In our weekly check, PolyPid Ltd. is graded F (A to F). Of 19 checks on debt, profit, cash flow and trend: 6 pass, warnings: 4, red flags: 9. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of PYPD stock?

This week's biggest flags for PolyPid Ltd.: Weak EPS forecast, Margins expected to shrink, Weak EPS growth. In total 13 of 19 checks show a warning or a red flag.

What does PolyPid Ltd. do?

PolyPid Ltd. is a Healthcare company (Biotechnology) based in Israel, listed on NASDAQ as PYPD.

When does PolyPid Ltd. report earnings next?

The next earnings report is expected on 2026-11-11. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis